Role of CBP in glucocorticoid-induced gene repression.
Imperial College School of Medicine, National Heart & Lung Institute, London, UK.
I M
IM
Adcock
Y
Y
Nasuhari
P J
PJ
Barnes
D000123:Acetyltransferases / Q000378:metabolism; D016207:Cytokines / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D005938:Glucocorticoids / Q000494:pharmacology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000378:metabolism; D051548:Histone Acetyltransferases; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D000068656:Mometasone Furoate; D011244:Pregnadienediols / Q000494:pharmacology*; D011965:Receptors, Glucocorticoid / Q000502:physiology*; D029701:Saccharomyces cerevisiae Proteins; D015534:Trans-Activators / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D016207:Cytokines; D005938:Glucocorticoids; D007375:Interleukin-1; D011244:Pregnadienediols; D011965:Receptors, Glucocorticoid; D029701:Saccharomyces cerevisiae Proteins; D015534:Trans-Activators; D000068656:Mometasone Furoate; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D000123:Acetyltransferases; D051548:Histone Acetyltransferases